ArticleThe Journal of international medical research2026
Evaluating the impact of statin therapy on chronic obstructive pulmonary disease outcomes: A retrospective cohort study from a tertiary care hospital in India.
Article in The Journal of international medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveChronic obstructive pulmonary disease is a common condition marked by significant disability and frequent exacerbations. Statins, owing to their anti-inflammatory and immunomodulatory effects, may offer therapeutic benefits in chronic obstructive pulmonary disease management. This retrospective cohort study evaluated the impact of statin use on chronic obstructive pulmonary disease outcomes in a subset of Indian population.MethodsPatients diagnosed with chronic obstructive pulmonary disease from January 2015 to December 2019 were divided into two equal groups of 83 patients each: statin users and nonusers. Primary outcomes included the annual exacerbation rate and number of hospitalizations, while secondary outcomes assessed exacerbation severity, emergency room visits, and duration of hospital stay over 1 year.ResultsStatin users showed a lower annual exacerbation rate (2.98 ± 1.9) compared to nonusers (3.51 ± 2.1), although this difference was not statistically significant (p = 0.058). Similarly, statin users had fewer hospitalizations (173 vs. 186; p = 0.493). However, the total duration of inpatient stays was significantly reduced in the statin group (1343 vs. 1518 days; p = 0.001). Outpatient and emergency visits were also lower among statin users, although these differences were not statistically significant.ConclusionStatin use in patients with chronic obstructive pulmonary disease exhibited a trend toward improved outcomes, particularly in reducing hospital stay duration, suggesting potential benefits that warrant further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.